# GC Wellbeing breaks ground on medical device GMP plant in Eumseong, South Korea

GC Wellbeing held a groundbreaking ceremony on November 2, 2026, for a medical device GMP plant in Eumseong, North Chungcheong Province, South Korea. The facility will produce dermal fillers and skin boosters, with completion targeted for the second quarter of 2027.

- Type: New facility
- Announced: 2026-11-02
- Where: Eumseong, North Chungcheong Province, South Korea
- Status: under construction
- Products: dermal fillers, skin boosters
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [GC Wellbeing](https://endata.com/companies/15312.md)
- [GC Biopharma](https://endata.com/companies/15313.md) (partner)

## Sources

- [en.sedaily.com](https://en.sedaily.com/technology/2026/11/03/gc-wellbeing-breaks-ground-on-medical-device-plant-for), 2026-11-03: "GC Wellbeing plans to apply the aseptic manufacturing technology and GMP-based quality control capabilities it has built up running its prescription drug business, centered on Laennec and nutritional injections, to the new facility."
- [en.fnnews.com](https://en.fnnews.com/news/202611031637183390), 2026-11-03: "GC Wellbeing said on the 3rd that it held a groundbreaking ceremony on the 2nd for a medical device manufacturing facility at GC Biopharma Corp.'s factory site in Eumseong, North Chungcheong Province."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.
